about the study

The Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL) aims to improve understanding of the causes and diagnosis of Alzheimer's disease, and help develop preventative strategies.

Launched on November 14 2006, the AIBL study is a prospective longitudinal study of ageing comprised of patients with Alzheimer's disease (AD), Mild Cognitive Impairment (MCI) and healthy volunteers.

The study will help researchers develop and confirm a set of diagnostic markers biomarkers and psychometrics that can be used to objectively monitor disease progression and to develop hypotheses about diet and lifestyle factors that might delay the onset of this disease.

Successful completion of this work will enable the design and conduct of extensive cohort studies that may lead to clinically proven preventative strategies for Alzheimer's disease.

Read more...

partner organisations

The AIBL study draws together experts in neuroimaging, biomarkers, neuropsychology, and lifestyle interventions, with scientists from:

Read more...